MedPath

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Phase 3
Completed
Conditions
Breast Cancer
Pain
Prostate Cancer
Metastatic Cancer
Registration Number
NCT00003162
Lead Sponsor
Radiation Therapy Oncology Group
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.

PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.

Detailed Description

OBJECTIVES:

* Compare the ability of a single fraction of radiation therapy vs multiple fractions to provide complete pain relief in patients with painful bone metastases from breast or prostate cancer.

* Determine the frequency and duration of pain relief and narcotic relief after these treatments in these patient populations.

* Compare the effect on quality of life of these two treatments in these patient populations.

* Compare the incidence of pathologic fracture within the treatment fields after these two treatments in these patient populations.

OUTLINE: This is a randomized study.

Patients are assigned to 1 of 2 treatment arms. Arm I consists of radiation therapy delivered in 10 fractions over 2 weeks. Arm II consists of a single dose of radiation therapy. Any retreatment does not occur until at least 4 weeks after prior treatment unless there is an increase of 2 points on the pain score.

Patients are followed and quality of life is assessed at 2 and 4 weeks, then at 2, 3, 6, 9, and 12 months, every 6 months for the next 3 years, then annually until death.

PROJECTED ACCRUAL: This study will accrue 938 patients within 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
949
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (253)

University of Alabama at Birmingham Comprehensive Cancer Center

🇺🇸

Birmingham, Alabama, United States

Huntsville Hospital System

🇺🇸

Huntsville, Alabama, United States

Comprehensive Cancer Institute of Huntsville

🇺🇸

Huntsville, Alabama, United States

MBCCOP - Gulf Coast

🇺🇸

Mobile, Alabama, United States

Alabama Oncology, LLC

🇺🇸

Montgomery, Alabama, United States

Radiation Oncology Associates of West Alabama

🇺🇸

Tuscaloosa, Alabama, United States

Foundation for Cancer Research and Education

🇺🇸

Phoenix, Arizona, United States

CCOP - Scottsdale Oncology Program

🇺🇸

Scottsdale, Arizona, United States

Mount Diablo Medical Center

🇺🇸

Concord, California, United States

Cancer Center and Beckman Research Institute, City of Hope

🇺🇸

Duarte, California, United States

Scroll for more (243 remaining)
University of Alabama at Birmingham Comprehensive Cancer Center
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.